Economic burden of patients with post-surgical chronic and transient hypoparathyroidism in the United States examined using insurance claims data

Abstract Background Hypoparathyroidism (HP) is a rare endocrine disease commonly caused by the removal or damage of parathyroid glands during surgery and resulting in transient (tHP) or chronic (cHP) disease. cHP is associated with multiple complications and comorbid conditions; however, the economi...

Full description

Bibliographic Details
Main Authors: Kathleen L Deering, Niccole J Larsen, Patrick Loustau, Blandine Weiss, Soraya Allas, Michael D Culler, Qing Harshaw, Deborah M. Mitchell
Format: Article
Language:English
Published: BMC 2024-04-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:https://doi.org/10.1186/s13023-024-03155-4
_version_ 1797199232283705344
author Kathleen L Deering
Niccole J Larsen
Patrick Loustau
Blandine Weiss
Soraya Allas
Michael D Culler
Qing Harshaw
Deborah M. Mitchell
author_facet Kathleen L Deering
Niccole J Larsen
Patrick Loustau
Blandine Weiss
Soraya Allas
Michael D Culler
Qing Harshaw
Deborah M. Mitchell
author_sort Kathleen L Deering
collection DOAJ
description Abstract Background Hypoparathyroidism (HP) is a rare endocrine disease commonly caused by the removal or damage of parathyroid glands during surgery and resulting in transient (tHP) or chronic (cHP) disease. cHP is associated with multiple complications and comorbid conditions; however, the economic burden has not been well characterized. The objective of this study was to evaluate the healthcare resource utilization (HCRU) and costs associated with post-surgical cHP, using tHP as a reference. Methods This analysis of a US claims database included patients with both an insurance claim for HP and thyroid/neck surgery between October 2014 and December 2019. cHP was defined as an HP claim ≥ 6 months following surgery and tHP was defined as only one HP claim < 6 months following surgery. The cHP index date was the first HP diagnosis claim following their qualifying surgery claim, whereas the tHP index date was the last HP diagnosis claim following the qualifying surgery claim. Patients were continuously enrolled at least 1 year pre- and post-index. Patients’ demographic and clinical characteristics, all-cause HCRU, and costs were descriptively analyzed. Total all-cause costs were calculated as the sum of payments for hospitalizations, emergency department, office/clinic visits, and pharmacy. Results A total of 1,406 cHP and 773 tHP patients met inclusion criteria. The average age (52.1 years cHP, 53.5 years tHP) and representation of females (83.2% cHP, 81.2% tHP) were similar for both groups. Neck dissection surgery was more prevalent in cHP patients (23.6%) than tHP patients (5.3%). During the 1–2 year follow-up period, cHP patients had a higher prevalence of inpatient admissions (17.4%), and emergency visits (26.0%) than the reference group -tHP patients (14.4% and 21.4% respectively). Among those with a hospitalization, the average number of hospitalizations was 1.5-fold higher for cHP patients. cHP patients also saw more specialists, including endocrinologists (28.7% cHP, 15.8% tHP), cardiologists (16.7% cHP, 9.7% tHP), and nephrologists (4.6% cHP, 3.3% tHP). Conclusion This study demonstrates the increased healthcare burden of cHP on the healthcare system in contrast to patients with tHP. Effective treatment options are needed to minimize the additional resources utilized by patients whose HP becomes chronic.
first_indexed 2024-04-24T07:12:29Z
format Article
id doaj.art-fdb8f9f61292477c95bcb5721d03e0e3
institution Directory Open Access Journal
issn 1750-1172
language English
last_indexed 2024-04-24T07:12:29Z
publishDate 2024-04-01
publisher BMC
record_format Article
series Orphanet Journal of Rare Diseases
spelling doaj.art-fdb8f9f61292477c95bcb5721d03e0e32024-04-21T11:30:23ZengBMCOrphanet Journal of Rare Diseases1750-11722024-04-011911910.1186/s13023-024-03155-4Economic burden of patients with post-surgical chronic and transient hypoparathyroidism in the United States examined using insurance claims dataKathleen L Deering0Niccole J Larsen1Patrick Loustau2Blandine Weiss3Soraya Allas4Michael D Culler5Qing Harshaw6Deborah M. Mitchell7EPI-Q, IncAmolyt PharmaAmolyt PharmaAmolyt PharmaAmolyt PharmaAmolyt PharmaEPI-Q, IncMassachusetts General HospitalAbstract Background Hypoparathyroidism (HP) is a rare endocrine disease commonly caused by the removal or damage of parathyroid glands during surgery and resulting in transient (tHP) or chronic (cHP) disease. cHP is associated with multiple complications and comorbid conditions; however, the economic burden has not been well characterized. The objective of this study was to evaluate the healthcare resource utilization (HCRU) and costs associated with post-surgical cHP, using tHP as a reference. Methods This analysis of a US claims database included patients with both an insurance claim for HP and thyroid/neck surgery between October 2014 and December 2019. cHP was defined as an HP claim ≥ 6 months following surgery and tHP was defined as only one HP claim < 6 months following surgery. The cHP index date was the first HP diagnosis claim following their qualifying surgery claim, whereas the tHP index date was the last HP diagnosis claim following the qualifying surgery claim. Patients were continuously enrolled at least 1 year pre- and post-index. Patients’ demographic and clinical characteristics, all-cause HCRU, and costs were descriptively analyzed. Total all-cause costs were calculated as the sum of payments for hospitalizations, emergency department, office/clinic visits, and pharmacy. Results A total of 1,406 cHP and 773 tHP patients met inclusion criteria. The average age (52.1 years cHP, 53.5 years tHP) and representation of females (83.2% cHP, 81.2% tHP) were similar for both groups. Neck dissection surgery was more prevalent in cHP patients (23.6%) than tHP patients (5.3%). During the 1–2 year follow-up period, cHP patients had a higher prevalence of inpatient admissions (17.4%), and emergency visits (26.0%) than the reference group -tHP patients (14.4% and 21.4% respectively). Among those with a hospitalization, the average number of hospitalizations was 1.5-fold higher for cHP patients. cHP patients also saw more specialists, including endocrinologists (28.7% cHP, 15.8% tHP), cardiologists (16.7% cHP, 9.7% tHP), and nephrologists (4.6% cHP, 3.3% tHP). Conclusion This study demonstrates the increased healthcare burden of cHP on the healthcare system in contrast to patients with tHP. Effective treatment options are needed to minimize the additional resources utilized by patients whose HP becomes chronic.https://doi.org/10.1186/s13023-024-03155-4Chronic hypoparathyroidismEconomic burdenHealthcare burdenCostsClaims analysis
spellingShingle Kathleen L Deering
Niccole J Larsen
Patrick Loustau
Blandine Weiss
Soraya Allas
Michael D Culler
Qing Harshaw
Deborah M. Mitchell
Economic burden of patients with post-surgical chronic and transient hypoparathyroidism in the United States examined using insurance claims data
Orphanet Journal of Rare Diseases
Chronic hypoparathyroidism
Economic burden
Healthcare burden
Costs
Claims analysis
title Economic burden of patients with post-surgical chronic and transient hypoparathyroidism in the United States examined using insurance claims data
title_full Economic burden of patients with post-surgical chronic and transient hypoparathyroidism in the United States examined using insurance claims data
title_fullStr Economic burden of patients with post-surgical chronic and transient hypoparathyroidism in the United States examined using insurance claims data
title_full_unstemmed Economic burden of patients with post-surgical chronic and transient hypoparathyroidism in the United States examined using insurance claims data
title_short Economic burden of patients with post-surgical chronic and transient hypoparathyroidism in the United States examined using insurance claims data
title_sort economic burden of patients with post surgical chronic and transient hypoparathyroidism in the united states examined using insurance claims data
topic Chronic hypoparathyroidism
Economic burden
Healthcare burden
Costs
Claims analysis
url https://doi.org/10.1186/s13023-024-03155-4
work_keys_str_mv AT kathleenldeering economicburdenofpatientswithpostsurgicalchronicandtransienthypoparathyroidismintheunitedstatesexaminedusinginsuranceclaimsdata
AT niccolejlarsen economicburdenofpatientswithpostsurgicalchronicandtransienthypoparathyroidismintheunitedstatesexaminedusinginsuranceclaimsdata
AT patrickloustau economicburdenofpatientswithpostsurgicalchronicandtransienthypoparathyroidismintheunitedstatesexaminedusinginsuranceclaimsdata
AT blandineweiss economicburdenofpatientswithpostsurgicalchronicandtransienthypoparathyroidismintheunitedstatesexaminedusinginsuranceclaimsdata
AT sorayaallas economicburdenofpatientswithpostsurgicalchronicandtransienthypoparathyroidismintheunitedstatesexaminedusinginsuranceclaimsdata
AT michaeldculler economicburdenofpatientswithpostsurgicalchronicandtransienthypoparathyroidismintheunitedstatesexaminedusinginsuranceclaimsdata
AT qingharshaw economicburdenofpatientswithpostsurgicalchronicandtransienthypoparathyroidismintheunitedstatesexaminedusinginsuranceclaimsdata
AT deborahmmitchell economicburdenofpatientswithpostsurgicalchronicandtransienthypoparathyroidismintheunitedstatesexaminedusinginsuranceclaimsdata